Standardising Serialisation: The Deadly World of Falsified and Substandard Medicines
Add bookmark
Standardising Serialisation: The Deadly World of Falsified and Substandard Medicines
Add bookmarkJust in the last few months, another dangerous fake drug made its way into the United States, a bogus version of the cancer drug Avastin surfaced in clinics across America in California, Illinois, and Texas. Recent changes to the EU Falsified Medicines Act mean that by 2015 most pharmaceutical companies trading in European countries will have to serialise their products, primarily using 2D data matrix barcodes. In this Pharma IQ exclusive AEI Scholar Roger Bate reveals how far-reaching the deadly business of counterfeit drugs has really become. Don't have the technology to listen to a podcast? Read the interview here: Roger Bate on the Deadly World of Falsified Medicines and the Financial Impact of Serialisation
[inlinead]
Have Your Say
Rate this feature and give us your feedback in the comments section below
